You are here: Home
 
Banner
Novartis receives EU approval for Farydak®, the first in its class of anticancer agents approved for patients with multiple myeloma

Novartis receives EU approval for Farydak®, the first in its class of anticancer agents approved for patients with multiple myeloma

Farydak (panobinostat) combination is approved in the EU for patients with multiple myeloma who received >=2 prior regimens including bortezomib and IMiD.

Shire to Attain Enhanced CINRYZE® Manufacturing Flexibility and Capacity

Shire to Attain Enhanced CINRYZE® Manufacturing Flexibility and Capacity

Shire to Attain Enhanced CINRYZE® Manufacturing Flexibility and Capacity

Novo Nordisk plans 2 billion US dollar investment in new production facilities in Clayton, North Carolina and Måløv, Denmark

Novo Nordisk plans 2 billion US dollar investment in new production facilities in Clayton, North Carolina and Måløv, Denmark

Novo Nordisk plans to invest an estimated 2 billion US dollars over the next five years in new production facilities in Clayton, North Carolina, US and Måløv, ...

Banner

Knowledge Bank

Edit

Amount of short articles:

Amount of articles links:

You can order sections with dragging on list bellow:

  • Knowledge Bank
Save
Cancel
Reset

News

Novartis receives two new FDA approvals for Cosentyx to treat patients with ankylosing spondylitis and psoriatic arthritis in the

Cosentyx is the first and only interleukin-17A (IL-17A) inhibitor approved for adult patients with ankylosing spondylitis (AS) and psoriatic arthritis

Thursday, 28 January 2016 Comments

Press Releases

U.S. Food And Drug Administration Approves Humulin® R U-500

The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's (NYSE: LLY) Humulin® R U-500 KwikPen®(insulin human injection) 500 units/mL, a pre-filled device containing Humulin R U-500,

Thursday, 28 January 2016 Comments

Research Insight

SINE™ Technology

A human cell is divided into various compartments, including the nucleus and the cytoplasm.  The nucleus contains a cell’s genetic material, or DNA, and is the compartment where gene expression

Thursday, 28 January 2016 Comments

Techno Trends

Novartis Access

The menace of noncommunicable diseases (NCDs) like cardiovascular diseases, diabetes and cancer in the developing world is increasing. These conditions disproportionally affect poverty-stricken areas. Already today 28 million people die

Friday, 29 January 2016 Comments

Industry Reports

INNATE PHARMA IN-LICENSES OREGA BIOTECH'S FIRST-IN-CLASS ANTI-CD39 CHECKPOINT INHIBITOR

This program, currently in preclinical development, aims at developing an anti-CD39 mAb; Targeting the adenosine immunosuppressive pathway has potential to promote anti-tumor immune responses across a wide range of tumors; Anti-CD39 broadens In

Thursday, 28 January 2016 Comments

Articles

Working Towards a Healthier

About one to two of every 1000 babies are born with hydrocephalus, a condition in which too much fluid builds up inside the skull. There is no cure, but treatment

Tuesday, 29 September 2015 Comments

Banner